Self-Administration of Burosumab in Children and Adults with X-Linked Hypophosphataemia in Two Open-Label, Single-Arm Clinical Studies

INTRODUCTION: X-linked hypophosphataemia (XLH) is a rare, genetic renal phosphate-wasting disease, resulting from excess fibroblast growth factor 23 (FGF23) activity, which has a progressive and profound impact on patients throughout life. The monoclonal anti-FGF23 antibody, burosumab, is a subcutan...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Takuo, Namba, Noriyuki, Tanaka, Hiroyuki, Muroya, Koji, Imanishi, Yasuo, Takeuchi, Yasuhiro, Kanematsu, Masanori, Sun, Wei, Seino, Yoshiki, Ozono, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887240/
https://www.ncbi.nlm.nih.gov/pubmed/36719566
http://dx.doi.org/10.1007/s12325-022-02412-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887240/
https://www.ncbi.nlm.nih.gov/pubmed/36719566
http://dx.doi.org/10.1007/s12325-022-02412-x

Ejemplares similares